Product Information

CEFADROXIL 250 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1796 per ML under NDC 57237009701. Its NADAC has been published 588 times since Mar 18, 2015.

FDA first approved this application on Apr 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFADROXIL 250 MG/5 ML SUSP

Cefadroxil
$0.1796per ML

Strength

250 mg/5mL

NDC

57237009701

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CEFADROXIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065349

FDA Approved

4/25/2013

TE Code

AB

On Market Since

4/25/2013

Pharmacological Classes

Price Statistics

The NADAC for CEFADROXIL 250 MG/5 ML SUSP has been published 588 times since Mar 18, 2015, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1796 per ML
All-time high$0.3316 (Mar 15, 2017)
All-time low$0.1470 (May 22, 2024)
52-week high$0.1967
52-week low$0.1707
Median price$0.2103
Average price$0.2218
Largest weekly change+44.7% (Jan 20, 2021)
Weeks tracked588
Tracking sinceMar 18, 2015

Price History

1W

-1.8%

1M

-1.8%

3M

-2.1%

6M

-8.5%

1Y

+4.4%

3Y

-19.6%

5Y

-26.2%

All

-43.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CEFADROXIL 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFADROXIL 250 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $0.1796 per ML (NDC 57237009701), effective Aug 19, 2026.

How has the price of CEFADROXIL 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFADROXIL 250 MG/5 ML SUSP has declined 43.6%. It has been tracked across 588 weekly CMS publications since Mar 18, 2015.

What are the highest and lowest recorded NADAC prices for CEFADROXIL 250 MG/5 ML SUSP?

Since Mar 18, 2015, the NADAC for CEFADROXIL 250 MG/5 ML SUSP has ranged from a low of $0.1470 (May 22, 2024) to a high of $0.3316 (Mar 15, 2017), with a median of $0.2103 per ML.

Are there cheaper alternatives to CEFADROXIL 250 MG/5 ML SUSP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFADROXIL 250 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures CEFADROXIL 250 MG/5 ML SUSP?

CEFADROXIL 250 MG/5 ML SUSP (NDC 57237009701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.